Background Allergic airway disease (AAD) is a chronic disease characterized by airway
inflammation, bronchoconstriction, and hyperresponsiveness. Although exogenous …

Background Particulate matter (PM) can exacerbate allergic airway diseases. Although
health effects of PM with a diameter of less than 100 nm have been focused, few studies …

Synthetic glycine coated 50 nm polystyrene nanoparticles (NP)(PS50G), unlike ambient NP,
do not promote pulmonary inflammation, but instead, render lungs resistant to the …

Background Asthma has been regarded as an inflammatory disease, and group 2 innate
lymphoid cells (ILC2s) are implicated in asthma pathogenesis. However, no strategy is …

Although the adverse health effects of nanoparticles have been proposed and are being
clarified, their aggravating effects on pre‐existing pathological conditions have not been fully …

Background Previous studies have shown that lipopolysaccharide (LPS)-activated bone
marrow-derived dendritic cells (DClps) might induce tolerance in autoimmune and cancer …

Asthma is a complex, heterogeneous chronic airway inflammatory disorder, which can be
simply categorized into eosinophilic and neutrophilic asthma. Although most patients with …

Drug resistance and the harmful side effects accompanying the prolonged corticosteroid
treatment of chronic pulmonary diseases prompted the development of more specific anti …

Allergic disease is a major global health concern that imposes significant life-altering and
economic burdens on affected individuals. However, there is still no cure. Polymer-based …

Specific immunotherapy (SIT) is the most widely used treatment for allergic diseases that
directly targets the T helper 2 (Th2) bias underlying allergy. However, the most widespread …